ArticleJournal of Cancer2021

A Novel Immunotype-based Risk Stratification Model Predicts Postoperative Prognosis and Adjuvant TACE Benefit in Chinese Patients with Hepatocellular Carcinoma.

Tian-En Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.